DỮ LIỆU BÁO CÁO THƯỜNG NIÊN
CÁC CÔNG TY NIÊM YẾT NƯỚC NGOÀI

Báo cáo thường niên năm 2020 của Takeda Pharmaceutical Company

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology … More (GI). They also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. They are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging their enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Their employees are committed to improving quality of life for patients and to working with their partners in health care in approximately 80 countries.

TÊN CÔNG TY / COMPANY
Takeda Pharmaceutical Company

SÀN CHỨNG KHOÁN / STOCK EXCHANGE
NYSE (US)

MÃ CHỨNG KHOÁN / TICKER
TAK

KỲ BÁO CÁO
2020

NGÀNH / INDUSTRY
Drug Manufacturers - Other

LĨNH VỰC / SECTOR
Healthcare